Skip to main content
Premium Trial:

Request an Annual Quote

VolitionRx Prices $7.5M Public Offering

NEW YORK – Epigenetics firm VolitionRx announced on Friday that it has priced an underwritten public offering of 4.3 million shares of its common stock at $1.75 per share, with expected gross proceeds of about $7.5 million.

Volition has also granted the underwriter a 30-day option to purchase up to an additional 645,000 shares of its common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments related to the offering, the company said in a statement. 

The firm said it intends to use the proceeds for research and continued product development, clinical studies, product commercialization, working capital, and other general corporate purposes, including potential strategic acquisitions. 

The offering is expected to close on Feb. 22, and Newbridge Securities is acting as the sole bookrunning manager of the offering.

In early morning trading on the Nasdaq, VolitionRx's shares were down 15 percent to $1.73.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.